Clearside Biomedical, Inc. Common Stock (CLSD) Income Statement (2016 - 2025)
Income Statement report data from Jun 30, 2016 to Sep 30, 2025 for Clearside Biomedical, Inc. Common Stock (CLSD).
Reported currency: USD
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | ||||||||||||||||||||||||||||||||||||||
Total Revenue | 200K (-59.18%) | 490K (-78.97%) | 2.33M (+651.61%) | 310K (-70.19%) | 1.04M (+1055.56%) | 90K (-60.87%) | 230K (-96.38%) | 6.35M (+638.37%) | 860K (-15.69%) | 1.02M | - | 330K (+22.22%) | 270K (-28.95%) | 380K (+8.57%) | 350K (-98.64%) | 26M (+736.81%) | 3.07M (+293.59%) | 780K (+2500.00%) | 30K (+200.00%) | 10K (-99.71%) | 3.43M (+880.00%) | 350K (-91.46%) | 4.10M (+111.34%) | 1.94M (+1285.71%) | 140K (+180.00%) | 50K (0.00%) | 50K | - | - | - | - | 60K (-62.50%) | 160K (+23.08%) | 130K (+1200.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K |
Cost Of Revenue | - | - | 250K (+66.67%) | 150K | - | - | - | - | 140K (-33.33%) | 210K | - | 200K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Costof Goods And Services Sold | - | - | 250K (+66.67%) | 150K | - | - | - | - | 140K (-33.33%) | 210K | - | 200K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit | 200K (-59.18%) | 490K (-76.44%) | 2.08M (+1200.00%) | 160K (-84.62%) | 1.04M (+1055.56%) | 90K (-60.87%) | 230K (-96.38%) | 6.35M (+781.94%) | 720K (-11.11%) | 810K | - | 130K (-51.85%) | 270K (-28.95%) | 380K (+8.57%) | 350K (-98.64%) | 26M (+736.81%) | 3.07M (+293.59%) | 780K (+2500.00%) | 30K (+200.00%) | 10K (-99.71%) | 3.43M (+880.00%) | 350K (-91.46%) | 4.10M (+111.34%) | 1.94M (+1285.71%) | 140K (+180.00%) | 50K (0.00%) | 50K | - | - | - | - | 60K (-62.50%) | 160K (+23.08%) | 130K (+1200.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K |
Operating Expenses | ||||||||||||||||||||||||||||||||||||||
Research And Development | 2.93M (+85.44%) | 1.58M (-64.57%) | 4.46M (+5.19%) | 4.24M (+2.66%) | 4.13M (-10.22%) | 4.60M (-18.15%) | 5.62M (-10.94%) | 6.31M (+23.00%) | 5.13M (+3.64%) | 4.95M (+11.24%) | 4.45M (-11.53%) | 5.03M (+8.41%) | 4.64M (-14.55%) | 5.43M (+19.60%) | 4.54M (+18.23%) | 3.84M (-25.44%) | 5.15M (+26.85%) | 4.06M (-26.05%) | 5.49M (+22.82%) | 4.47M (+28.08%) | 3.49M (+5.76%) | 3.30M (-13.39%) | 3.81M (+190.84%) | 1.31M (-52.01%) | 2.73M (+313.64%) | 660K (-93.98%) | 11M (-37.28%) | 17M (-12.90%) | 20M (+15.80%) | 17M (+29.60%) | 13M (-4.02%) | 14M (-13.15%) | 16M (+39.81%) | 11M (+51.25%) | 7.59M (+8.90%) | 6.97M (+89.40%) | 3.68M (-12.59%) | 4.21M |
Selling General And Administrative | 4.31M (+73.79%) | 2.48M (-12.06%) | 2.82M (-7.84%) | 3.06M (+7.75%) | 2.84M (-7.79%) | 3.08M (+9.22%) | 2.82M (-4.41%) | 2.95M (+11.74%) | 2.64M (-15.65%) | 3.13M (-0.95%) | 3.16M (-0.32%) | 3.17M (+34.89%) | 2.35M (-15.77%) | 2.79M (-19.36%) | 3.46M (+10.19%) | 3.14M (+11.35%) | 2.82M (0.00%) | 2.82M (-2.42%) | 2.89M (+9.06%) | 2.65M (+11.81%) | 2.37M (-9.20%) | 2.61M (-16.35%) | 3.12M (-14.52%) | 3.65M (-3.44%) | 3.78M (-24.40%) | 5.00M (+14.16%) | 4.38M (+4.78%) | 4.18M (+8.01%) | 3.87M (+8.71%) | 3.56M (+15.96%) | 3.07M (+25.82%) | 2.44M (+6.09%) | 2.30M (+0.44%) | 2.29M (-14.23%) | 2.67M (+11.72%) | 2.39M (+46.63%) | 1.63M (+68.04%) | 970K |
Operating Expenses | 3.67M (-9.61%) | 4.06M (-42.66%) | 7.08M (-12.48%) | 8.09M (+22.39%) | 6.61M (-13.93%) | 7.68M (-22.74%) | 9.94M (+7.34%) | 9.26M (+19.18%) | 7.77M (-3.72%) | 8.07M (+6.04%) | 7.61M (-7.20%) | 8.20M (+17.31%) | 6.99M (-14.96%) | 8.22M (+2.88%) | 7.99M (+14.47%) | 6.98M (-12.31%) | 7.96M (+15.70%) | 6.88M (-17.90%) | 8.38M (+17.70%) | 7.12M (+21.50%) | 5.86M (-0.85%) | 5.91M (-14.72%) | 6.93M (+39.72%) | 4.96M (-23.81%) | 6.51M (+15.02%) | 5.66M (-63.13%) | 15M (-29.13%) | 22M (-9.60%) | 24M (+14.64%) | 21M (+27.05%) | 16M (+0.43%) | 16M (-10.74%) | 18M (+33.26%) | 14M (+34.21%) | 10M (+9.62%) | 9.36M (+76.27%) | 5.31M (+2.51%) | 5.18M |
Operating Income | ||||||||||||||||||||||||||||||||||||||
Operating Income | -3.47M (-2.80%) | -3.57M (-28.60%) | -5.00M (-36.95%) | -7.93M (+42.37%) | -5.57M (-26.61%) | -7.59M (-21.83%) | -9.71M (+233.68%) | -2.91M (-58.72%) | -7.05M (-3.03%) | -7.27M (-4.34%) | -7.60M (-5.82%) | -8.07M (+20.09%) | -6.72M (-14.29%) | -7.84M (+2.48%) | -7.65M | 19M | -4.89M (-19.84%) | -6.10M (-26.95%) | -8.35M (+17.44%) | -7.11M (+192.59%) | -2.43M (-56.29%) | -5.56M (+95.77%) | -2.84M (-5.65%) | -3.01M (-52.75%) | -6.37M (+13.35%) | -5.62M (-63.29%) | -15.31M (-29.22%) | -21.63M (-9.72%) | -23.96M (+14.64%) | -20.90M (+27.05%) | -16.45M (+0.80%) | -16.32M (-10.28%) | -18.19M (+33.36%) | -13.64M (+32.94%) | -10.26M (+9.62%) | -9.36M (+76.27%) | -5.31M (+2.51%) | -5.18M |
EBITDA | -3.38M (-2.87%) | -3.48M (-29.12%) | -4.91M (-37.93%) | -7.91M (+39.51%) | -5.67M (-25.88%) | -7.65M (-20.97%) | -9.68M (+234.95%) | -2.89M (-58.95%) | -7.04M (-2.90%) | -7.25M (-4.48%) | -7.59M (-5.71%) | -8.05M (+20.51%) | -6.68M (-14.36%) | -7.80M (+2.63%) | -7.60M | 19M | -4.84M (-20.00%) | -6.05M (-27.11%) | -8.30M (+17.40%) | -7.07M (+195.82%) | -2.39M (-56.62%) | -5.51M (+97.49%) | -2.79M (-5.74%) | -2.96M (-53.09%) | -6.31M (+13.49%) | -5.56M (-63.54%) | -15.25M (-29.33%) | -21.58M (-9.74%) | -23.91M (+14.62%) | -20.86M (+27.12%) | -16.41M (+0.86%) | -16.27M (-10.31%) | -18.14M (+33.58%) | -13.58M (+32.75%) | -10.23M (+9.53%) | -9.34M (+76.56%) | -5.29M (+2.52%) | -5.16M |
Other Income / Expenses | ||||||||||||||||||||||||||||||||||||||
Interest Income | 70K (-41.67%) | 120K (-25.00%) | 160K (-55.56%) | 360K (+5.88%) | 340K (-19.05%) | 420K (+20.00%) | 350K (-2.78%) | 360K (-12.20%) | 410K (-10.87%) | 460K (-6.12%) | 490K (-26.87%) | 670K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense | -2.57M (-6.88%) | -2.76M (+3.37%) | -2.67M (+3.49%) | -2.58M (+4.88%) | -2.46M (+5.13%) | -2.34M (-2.50%) | -2.40M (+5.26%) | -2.28M (-12.98%) | -2.62M (+14.41%) | -2.29M (+5.53%) | -2.17M (-35.03%) | -3.34M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Interest Income | 2.64M (-8.33%) | 2.88M (+1.41%) | 2.84M (-3.40%) | 2.94M (+5.00%) | 2.80M (+1.45%) | 2.76M (+0.36%) | 2.75M (+4.17%) | 2.64M (-12.87%) | 3.03M (+10.18%) | 2.75M (+3.38%) | 2.66M (-33.67%) | 4.01M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Other Non Operating Income | - | 1.72M | - | 2.85M | - | 1.92M | - | - | - | - | - | - | -1.10M | 20K | - | - | - | - | 1.00M | - | - | -200.00K (+185.71%) | -70.00K (-12.50%) | -80.00K (-52.94%) | -170.00K (+41.67%) | -120.00K (+20.00%) | -100.00K (+900.00%) | -10.00K | 80K (-60.00%) | 200K | -150.00K (-11.76%) | -170.00K (+21.43%) | -140.00K (+7.69%) | -130.00K (+8.33%) | -120.00K (-63.64%) | -330.00K (-2.94%) | -340.00K | 80K |
Net Income | ||||||||||||||||||||||||||||||||||||||
Income Before Tax | -5.97M (+32.96%) | -4.49M (-40.21%) | -7.51M (+2.74%) | -7.31M (-4.94%) | -7.69M (+1.32%) | -7.59M (-35.46%) | -11.76M (+143.48%) | -4.83M (-47.90%) | -9.27M (+1.76%) | -9.11M (-1.83%) | -9.28M (-3.93%) | -9.66M (+23.37%) | -7.83M (+0.26%) | -7.81M (+2.23%) | -7.64M | 19M | -4.89M (-19.70%) | -6.09M (-17.14%) | -7.35M (+3.38%) | -7.11M (+192.59%) | -2.43M (-57.74%) | -5.75M (+97.59%) | -2.91M (-6.13%) | -3.10M (-52.60%) | -6.54M (+14.14%) | -5.73M (-62.79%) | -15.40M (-28.84%) | -21.64M (-9.34%) | -23.87M (+15.31%) | -20.70M (+24.62%) | -16.61M (+0.73%) | -16.49M (-10.09%) | -18.34M (+33.19%) | -13.77M (+32.79%) | -10.37M (+7.02%) | -9.69M (+71.81%) | -5.64M (+10.59%) | -5.10M |
Income Tax Expense | - | - | 720K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income From Continuing Operations | -5.97M (+32.96%) | -4.49M (-45.38%) | -8.22M (+12.45%) | -7.31M (-4.94%) | -7.69M (+1.32%) | -7.59M (-35.46%) | -11.76M (+143.48%) | -4.83M (-47.90%) | -9.27M (+1.76%) | -9.11M (-1.83%) | -9.28M (-3.93%) | -9.66M (+23.37%) | -7.83M (+0.26%) | -7.81M (+2.23%) | -7.64M | 19M | -4.89M (-19.70%) | -6.09M (-17.14%) | -7.35M (+3.38%) | -7.11M (+192.59%) | -2.43M (-57.74%) | -5.75M (+97.59%) | -2.91M (-6.13%) | -3.10M (-52.60%) | -6.54M (+14.14%) | -5.73M (-62.79%) | -15.40M (-28.84%) | -21.64M (-9.34%) | -23.87M (+15.31%) | -20.70M (+24.62%) | -16.61M (+0.73%) | -16.49M (-10.09%) | -18.34M (+33.19%) | -13.77M (+32.79%) | -10.37M (+7.02%) | -9.69M (+71.81%) | -5.64M (+10.59%) | -5.10M |
Net Income | -5.97M (+32.96%) | -4.49M (-45.38%) | -8.22M (+12.45%) | -7.31M (-4.94%) | -7.69M (+1.32%) | -7.59M (-35.46%) | -11.76M (+143.48%) | -4.83M (-47.90%) | -9.27M (+1.76%) | -9.11M (-1.83%) | -9.28M (-3.93%) | -9.66M (+23.37%) | -7.83M (+0.26%) | -7.81M (+2.23%) | -7.64M | 19M | -4.89M (-19.70%) | -6.09M (-17.14%) | -7.35M (+3.38%) | -7.11M (+192.59%) | -2.43M (-57.74%) | -5.75M (+97.59%) | -2.91M (-6.13%) | -3.10M (-52.60%) | -6.54M (+14.14%) | -5.73M (-62.79%) | -15.40M (-28.84%) | -21.64M (-9.34%) | -23.87M (+15.31%) | -20.70M (+24.62%) | -16.61M (+0.73%) | -16.49M (-10.09%) | -18.34M (+33.19%) | -13.77M (+32.79%) | -10.37M (+7.02%) | -9.69M (+71.81%) | -5.64M (+10.59%) | -5.10M |